Fujifilm partners with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan Licensing agreement was signed on the development, manufacture and sales of anti-influenza virus drug Avigan® Tablets. TOKYO, July 1, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) partners with Dr. Reddy’s Laboratories Ltd. (Co-Chairman & Managing Director: G. […]
FUJIFILM Wako Introduces Line of Endotoxin Detection Reagents to U.S. Market PYROSTAR™ ES-F line for endotoxin detection poised to support quality assurance process of future COVID-19 vaccine manufacturing Richmond, Virginia, June 25, 2020 – FUJIFILM Wako Chemicals U.S.A. Corporation (FUJIFILM Wako), a wholly owned subsidiary of FUJIFILM Wako Pure Chemical Corporation of Japan, announced the U.S. introduction of the PYROSTAR™ ES-F line of limulus amebocyte lysate (LAL) reagents, which are engineered to detect the presence of bacterial endotoxins. The detection […]
Our Commitment to Inclusiveness and Diversity A Message from Us to Our Community Diversity is where we find our strength, and this is especially true for creators. We’ve engaged with and listened to our communities, scrutinized our marketing programs, and now it is time for us to do more. To impart meaningful change, words are […]
Significant expansion of production facilities for biopharmaceuticals in Denmark Accelerate expansion of outsourced biopharmaceutical development and manufacturing business with large investment of 100 billion yen Doubled the production capacity of the drug substance, and established a contracted system that allows one-site, one-stop support from the drug substance to formulation and packaging FUJIFILM Corporation (President: Kenji Sukeno ) […]
New Co-authored Book from Fujifilm Chairman Shigetaka Komori and Professor Philip Kotler Published ‘Never Stop – Winning through Innovation’ Offers a glimpse into why, how and what to innovate amid an unpredictable environment A book ‘Never Stop – Winning through Innovation’ is written collaboratively by authors, Professor Philip Kotler of the Kellogg School of Management […]
Tonix Pharmaceuticals Announces FUJIFILM Diosynth Biotechnologies to be Manufacturing Partner for COVID-19 Vaccine Candidate TNX-1800 Collaboration includes Development of Manufacturing Processes and to Supply Clinical Trial Material to Support Tonix’s Development of TNX-1800 NEW YORK, June 01, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, […]